Image de couverture de livre

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	De‐Kui Qiu, Si‐Ping Yan, Rui‐Tong Chen, Shu‐Yu Wu, Mei‐Feng Nie, Man Yang, Yue Liu, Yang‐Tao Wu, Hua‐Long Xiong, Quan Yuan, Jun Zhang, Tian‐Ying Zhang, Ruo‐Yao Qi, Ying‐Bin Wang
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	British Journal of Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
par: Yali Gao, et autres
Publié: (2026)

How could perampanel, a potent AMPAergic antagonist, inhibit seizures but largely spare normal neurotransmission?
par: Cho‐Ming Lee, et autres
Publié: (2026)

A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
par: Marvin Xuejun Xu, et autres
Publié: (2025)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
par: Mei‐Mei Zhao, et autres
Publié: (2024)

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
par: Shibeilei Lin, et autres
Publié: (2025)

Biomimetic MCC950‐loaded cerium‐layered double hydroxide nanoparticles for targeted treatment of Type 1 diabetes in streptozotocin‐induced mice
par: Huiwen Pang, et autres
Publié: (2026)

Exploring the antidepressant potential of Yueju Pill: Insights from traditional Chinese medicine
par: Xinyan Wu, et autres
Publié: (2026)

FGF1ΔHBS ameliorates DSS‐induced ulcerative colitis by reducing neutrophil recruitment through the MAPK pathway
par: Shuang Feng, et autres
Publié: (2025)

Trained immunity: A link between risk factors and cardiovascular disease
par: Mingqi Chen, et autres
Publié: (2024)

Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription
par: Patrick G. Schweickert, et autres
Publié: (2025)

7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction
par: Ju‐Ying Tsai, et autres
Publié: (2025)

Model‐based population pharmacokinetic and exposure response analyses for safety and efficacy of nivolumab as adjuvant treatment in subjects with resected oesophageal or gastroesophageal junction cancer
par: Yue Zhao, et autres
Publié: (2024)

Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway
par: Yi‐Wen Nie, et autres
Publié: (2025)

Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases
par: Meng Qi, et autres
Publié: (2024)

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
par: Andrea Baragetti, et autres
Publié: (2026)

Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis
par: Jin‐Meng Li, et autres
Publié: (2024)

GI‐Y2, a novel gasdermin D inhibitor, attenuates sepsis‐induced myocardial dysfunction by inhibiting gasdermin D‐mediated pyroptosis in macrophages
par: Yiling Mei, et autres
Publié: (2025)

A novel peptide‐fentanyl conjugate with μ‐opioid and neuropeptide FF receptor agonism produces antinociception with limited side effects in male mice
par: Ning Li, et autres
Publié: (2025)

Ginsenoside Rf protects against acetaminophen‐induced liver injury by targeting CCAR2 to activate the SIRT1‐FXR signalling pathway
par: Jingjing Fan, et autres
Publié: (2026)

CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8 + T cell‐ and NK cell‐dependent tumour immune escape
par: Fanglin Li, et autres
Publié: (2026)

Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF‐κB‐mediated inflammation and alleviate atherosclerosis
par: Sirui Shen, et autres
Publié: (2026)

GL‐V9 inhibits Caspase‐11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis
par: Li Chen, et autres
Publié: (2025)

Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel
par: Chen Pan, et autres
Publié: (2024)

The efficacy of hydroxychloroquine in paediatric chronic immune thrombocytopenia: A retrospective cohort study
par: Jing Liu, et autres
Publié: (2025)

The plant extract PNS mitigates atherosclerosis via promoting Nrf2‐mediated inhibition of ferroptosis through reducing USP2‐mediated Keap1 deubiquitination
par: Yun Zhao, et autres
Publié: (2024)

Trajectory of lipid profiles in rheumatoid arthritis patients receiving tofacitinib: Evidence from the prospective CENTRA cohort
par: Hong Huang, et autres
Publié: (2026)

Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver
par: Marine Andres, et autres
Publié: (2024)

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy
par: Wen‐Hui Liu, et autres
Publié: (2026)

Comparing the efficacy of efgartigimod and intravenous immunoglobulin on AQP4‐IgG‐positive neuromyelitis optica spectrum disorder during acute attacks
par: Jia Liu, et autres
Publié: (2025)

Baclofen modulates the immune response after spinal cord injury with locomotor benefits
par: Nídia de Sousa, et autres
Publié: (2025)

Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction
par: David F. Colón, et autres
Publié: (2024)

V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
par: Shasha Jin, et autres
Publié: (2024)

Comment on ‘Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study’
par: Jia Chen, et autres
Publié: (2026)

Investigation of absorption, metabolism, and excretion of [ 14 C]pruxelutamide (GT0918), an androgen receptor antagonist in humans
par: Yuan‐dong Zheng, et autres
Publié: (2025)

Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair
par: Yujie Peng, et autres
Publié: (2026)

Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
par: Jin‐Ru Zou, et autres
Publié: (2026)

CircPTK2 enhances non‐small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1
par: Qiuhui Li, et autres
Publié: (2025)

Effects of vaccines targeting interleukin‐1 receptor, type I on atrial and ventricular function after myocardial infarction
par: Jianwu Huang, et autres
Publié: (2026)

Kynurenic acid as a promising therapeutic agent in renal fibrosis: dual modulation of fibrosis and immune crosstalk
par: Sona Sykorova, et autres
Publié: (2026)

Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer
par: Timothée David, et autres
Publié: (2024)